128 related articles for article (PubMed ID: 11358841)
1. Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors.
Wang VW; Bell DA; Berkowitz RS; Mok SC
Cancer Res; 2001 May; 61(10):4169-74. PubMed ID: 11358841
[TBL] [Abstract][Full Text] [Related]
2. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
[TBL] [Abstract][Full Text] [Related]
3. Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.
Tuhkanen H; Anttila M; Kosma VM; Puolakka J; Juhola M; Heinonen S; Mannermaa A
Gynecol Oncol; 2004 Aug; 94(2):416-21. PubMed ID: 15297182
[TBL] [Abstract][Full Text] [Related]
4. Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors.
Rodabaugh KJ; Blanchard G; Welch WR; Bell DA; Berkowitz RS; Mok SC
Cancer Res; 1995 May; 55(10):2169-72. PubMed ID: 7743519
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.
Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R
Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
[TBL] [Abstract][Full Text] [Related]
7. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
[TBL] [Abstract][Full Text] [Related]
8. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
[TBL] [Abstract][Full Text] [Related]
9. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
[TBL] [Abstract][Full Text] [Related]
11. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer.
Shridhar V; Staub J; Huntley B; Cliby W; Jenkins R; Pass HI; Hartmann L; Smith DI
Oncogene; 1999 Jul; 18(26):3913-8. PubMed ID: 10445856
[TBL] [Abstract][Full Text] [Related]
12. [Refined mapping of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer].
Xu SF; Li DP; Peng ZH
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):413-7. PubMed ID: 19024513
[TBL] [Abstract][Full Text] [Related]
13. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF
Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854
[TBL] [Abstract][Full Text] [Related]
15. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483
[TBL] [Abstract][Full Text] [Related]
16. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.
Zenklusen JC; Weitzel JN; Ball HG; Conti CJ
Oncogene; 1995 Jul; 11(2):359-63. PubMed ID: 7624150
[TBL] [Abstract][Full Text] [Related]
17. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.
Shridhar V; Sen A; Chien J; Staub J; Avula R; Kovats S; Lee J; Lillie J; Smith DI
Cancer Res; 2002 Jan; 62(1):262-70. PubMed ID: 11782386
[TBL] [Abstract][Full Text] [Related]
18. High resolution allelotype of microdissected primary nasopharyngeal carcinoma.
Lo KW; Teo PM; Hui AB; To KF; Tsang YS; Chan SY; Mak KF; Lee JC; Huang DP
Cancer Res; 2000 Jul; 60(13):3348-53. PubMed ID: 10910036
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors.
Brown MR; Chuaqui R; Vocke CD; Berchuck A; Middleton LP; Emmert-Buck MR; Kohn EC
Gynecol Oncol; 1999 Jul; 74(1):98-102. PubMed ID: 10385558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
